1 23/10/2015
Strengthening our Success Central Procurement and Supplies Unit Department of Health Ministry for Energy & Health [Health] Ing Karl Farrugia Chief Executive Officer Malta Chamber of Commerce, Enterprise Industry, Valletta 23 rd October 2015
Objectives To enhance the significant collaboration, which has been established between the Government of Malta and the Malta Chamber of Commerce, Enterprise and Industry To strengthen the acquisition and supply chain that may improve the over-arching commitment to high-quality patient care service To renovate and upgrade the legal and regulatory framework and supply chain strategy focusing on Information technology solutions
6 23/10/2015
Our Strengths & Weaknesses Global Shortages Working in close liaison to mitigate and be proactive by securing stocks or alternatives. Medicine Alerts are being issued to guide HCPs. Setting a web/sms link. Quality of products: Declaration of Conformity being requested as MANDATORY Technical document uploaded on ePPS: to avoid uploading catalogues and highlights Counterfeits, ethical issues related to supplies being reported to the relevant authorities including MCCA/MA/DOC/COC Key Performance Targets Strengthening adjudications by setting up in-house experts to maintain a faster closed processes Supporting economical operators in submitting a more complete and less bureaucratic offers
Our Success Regular Forecasts of requirements through staggered orders and visibility of demands and annual consumptions on website portal Supplier/Client Performance - Open channels of communication and feedback Website: http://health.gov.mt/en/cpsu/Pages/Home.aspx Facebook: https://www.facebook.com/CPSUMFH Meetings Online assistance Single bonds activated Setting up of Time-based Agreements for Medicines Setting procedures to involve relevant stakeholders to facilitate process including MCCAA, DOC Drastic improvements in suppressing Stock Outs
23/10/2015
Improved Supplier ’ s Performance Penalties imposed over the last 5 years € 918,587 € 652,473 € 619,455 € 428,260 € 114,739.55 2011 2012 2013 2014 2015
Improved Payment Terms Creditors over 60 Days € 16,000,000.00 € 14,000,000.00 € 12,000,000.00 € 10,000,000.00 € 8,000,000.00 2015 2014 2013 € 6,000,000.00 € 4,000,000.00 € 2,000,000.00 € -
Timebased Pharma Contracts Vaccines Blood Anaesthesia Central Nervous System Musculoskeletal & Joint Disease Renal High Volume priority pharma Controlled drugs Cardiovascular System Drugs Group I Chemicals Cardiovascular System Drugs Group II Ear, Nose and Throat Cardiovascular System Drugs Group III Fluids Cardiovascular System Drugs Group IV Gastro intestinal Anti Infectives - Group I - Antibacterials Gynaecology Anti Infectives - Group II - Antibacterials Radiopharmaceuticals Anti Infectives - Group III - Antibacterials Contrast Media Anti Infectives - Group IV - Antivirals & Antiretrovital Nutrition Anti Infectives - Group V - Antihelmintic, Antiprotozoal Obstetrics & Malaria Treatment Anti Infective - Group VI - Antifungal Ophthalmic Anti Epileptic Drugs Parenteral Nutrition Immunosuppressant Respiratory Skin Oncology Antihistamines Urinary Biological Other medicines Diabetes Non-medicines
Projects 2015-2016 Setting up of specifications and a formulary of Medical Materials and Surgical Devices based on international standards Enterprise Resource Planning System to patient level: Inventory Management System Forecasting Demand Reduction in Medical Error / Wastages Pharmaceutical Automation/Distribution System Intelligent Storage modules Package Deals First offers received and being assessed
CPSU: Expectations for 2016? Suppression of shortages Joint Procurement Suppliers to hold stocks Time – based agreements Company Profiling Suppliers ’ grading in collaboration with COC & DOC Grading to be latched to performance guarantees Robust system to ensure quality of service and products Wastage & Medical Error Reduction Web based inventory management system Barcode/RFID stock control Electronic prescribing
Industry: Expectations for 2016?
Strengthening our Success
Recommend
More recommend
